Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 5/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | S100A4 | P26447 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1247110 | 0.81 | TDP1 (0.40) | ELANEMAPTALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL2965652 | 0.75 | S100A4 (0.39) | ALDH1A1NPC1RAB9ATDP1MAOB | |
| SCHEMBL324177 | 0.73 | MAOB (0.44) | ELANEALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL6981693 | 0.72 | LMNA (0.39) | ELANEMAPTALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL24245 | 0.70 | APP (0.35) | CYP3A4NPC1RAB9AS100A4SMN1; SMN2 | |
| SCHEMBL18905 | 0.70 | POLB (0.55) | MAPTCYP1A2CYP3A4MEN1KMT2A | |
| SCHEMBL6469994 | 0.69 | RAB9A (0.49) | MAPTALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL17438712 | 0.69 | RAB9A (0.47) | MAPTALDH1A1CYP1A2MEN1KMT2A | |
| SCHEMBL7447169 | 0.68 | MAPT (0.31) | MAPTALDH1A1MEN1KMT2ARAB9A | |
| SCHEMBL1707607 | 0.67 | RAB9A (0.41) | ELANEMAPTALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7365113-B2 | Phosphate ester flame retardants from resorcinol-ketone reaction products | INDSPEC CHEMICAL CORPORATION | 2008-04-29 | — | — | US | claimed |
| US-7279515-B2 | Resorcinol carbonate-based phosphate ester compounds as flame retardants | INDSPEC CHEMICAL CORPORATION | 2007-10-09 | — | — | US | claimed |
| US-20060210896-A1 | Aromatic amine-based charge transport materials having an N,N-divinyl group | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2006-09-21 | — | — | US | claimed |
| US-8193372-B2 | Phosphothiophene and phosphothiazole HCV polymerase inhibitors | IDENIX PHARMACEUTICALS, INC. (US) | 2012-06-05 | — | — | US | disclosed |
| EP-2403860-A2 | PHOSPHOTHIOPHENE AND PHOSPHOTHIAZOLE AS HCV POLYMERASE INHIBITORS | IDENIX Pharmaceuticals, Inc. (US) | 2012-01-11 | — | — | EP | disclosed |
| US-20100233123-A1 | PHOSPHOTHIOPHENE AND PHOSPHOTHIAZOLE HCV POLYMERASE INHIBITORS | IDENIX PHARMACEUTICALS, INC. (US) | 2010-09-16 | — | — | US | disclosed |
| WO-2010101967-A2 | PHOSPHOTHIOPHENE AND PHOSPHOTHIAZOLE HCV POLYMERASE INHIBITORS | IDENIX PHARMACEUTICALS, INC. (US) | 2010-09-10 | — | — | WO | disclosed |
| US-7534541-B2 | Heterocycle-hydrazone based charge transport materials | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-05-19 | — | — | US | disclosed |
| US-7452641-B2 | Electrophotographic organophotoreceptors with novel charge transport compounds | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-11-18 | — | — | US | disclosed |
| US-7439289-B2 | Benzoylresorcinol-based phosphate ester compounds as flame retardants | INDSPEC CHEMICAL CORPORATION (US) | 2008-10-21 | — | — | US | disclosed |
| US-7378203-B2 | Ferrocene(di)carboxaldehyde N-phenylhydrazone and monomeric, bridged or polymeric derivatives; good mechanical and electrostatic properties; can be used with liquid and dry toners to produce high quality images; imaging systems can be maintained after repeated cycling; electrography | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-05-27 | — | — | US | disclosed |
| US-20060177750-A1 | Charge transport materials having a nitrogen-containing-heterocycle hydrazone group | S-PRINTING SOLUTION CO., LTD. (KR) | 2006-08-10 | — | — | US | disclosed |
| US-20060166118-A1 | Heterocycle-hydrazone based charge transport materials | S-PRINTING SOLUTION CO., LTD. (KR) | 2006-07-27 | — | — | US | disclosed |
| WO-2006036891-A2 | BENZOYLRESORCINOL-BASED PHOSPHATE ESTER COMPOUDS AS FLAME RETARDANTS | INDSPEC CHEMICAL CORPORATION (US) | 2006-04-06 | — | — | WO | disclosed |
| WO-2006036881-A2 | RESORCINOL CARBONATE-BASED PHOSPHATE ESTER COMPOUNDS AS FLAME RETARDANTS | INDSPEC CHEMICAL CORPORATION (US) | 2006-04-06 | — | — | WO | disclosed |
| WO-2006036880-A2 | PHOSPHATE ESTER FLAME RETRADANTS FROM RESORCINOL-KETONE REACTION PRODUCTS | INDSPEC CHEMICAL CORPORATION (US) | 2006-04-06 | — | — | WO | disclosed |
| US-20060063866-A1 | Resorcinol carbonate-based phosphate ester compounds as flame retardants | INDSPEC CHEMICAL CORPORATION (US) | 2006-03-23 | — | — | US | disclosed |
| US-20060063867-A1 | Phosphate ester flame retardants from resorcinol-ketone reaction products | INDSPEC CHEMICAL CORPORATION (US) | 2006-03-23 | — | — | US | disclosed |
| US-20060063865-A1 | Benzoylresorcinol-based phosphate ester compounds as flame retardants | INDSPEC CHEMICAL CORPORATION (US) | 2006-03-23 | — | — | US | disclosed |
| US-20050147906-A1 | Electrophotographic organophotoreceptors with novel charge transport compounds | S-PRINTING SOLUTION CO., LTD. (KR) | 2005-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060166118-A1 | Heterocycle-hydrazone based charge transport materials | AQP1, SLC9B2, SLC9A2 | ELANE 1862/4885MAPT 4672/4885ALDH1A1 930/4885 |
| US-20060210896-A1 | Aromatic amine-based charge transport materials having an N,N-divinyl group | SLC18A1, SLC18A2, SLC6A19 | ELANE 1265/4885MAPT 1823/4885ALDH1A1 2059/4885 |
| US-20060177750-A1 | Charge transport materials having a nitrogen-containing-heterocycle hydrazone group | SLC1A2, SLC9B2, SLC6A19 | ELANE 674/4885MAPT 4102/4885ALDH1A1 1928/4885 |
| US-20100233123-A1 | PHOSPHOTHIOPHENE AND PHOSPHOTHIAZOLE HCV POLYMERASE INHIBITORS | PPP3CB, POLR2E, PSAT1 | ELANE 2470/4885MAPT 1176/4885ALDH1A1 1224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.